("DyDo") has launched FIRDAPSE (amifampridine) Tablets 10 mg in Japan for the indication of improving muscle weakness in patients living with Lambert-Eaton myasthenic syndrome ("LEMS"). "We are ...

Lambert-Eaton myasthenic syndrome (LEMS) is a rare neuromuscular junction disorder. Underlying small cell lung cancer is found in more than half of patients. Proximal muscle weakness, autonomic ...

CORAL GABLES, Fla. - Catalyst Pharmaceuticals Inc. (NASDAQ:CPRX), a pharmaceutical company demonstrating excellent financial health according to InvestingPro metrics, announced today that its Japanese ...

This pharma stock has made strong gains over the past 12 months thanks to its strong earnings. Now it is testing a fresh buy ...

("DyDo") has launched FIRDAPSE ® (amifampridine) Tablets 10 mg in Japan for the indication of improving muscle weakness in patients living with Lambert-Eaton myasthenic syndrome ("LEMS ... channel ...

David McNew/Getty The Palisades and Eaton wildfires — which devastated neighborhoods across Los Angeles County, including Pacific Palisades, Malibu, Pasadena and Altadena — have officially ...

Eaton ( NYSE:ETN ) Full Year 2024 Results Key Financial Results Revenue: US$24.9b (up 7.3% from FY 2023). Net income... Eaton Corp PLC (ETN) reports robust financial performance with a record ...

There are a wide variety of neurological diseases affecting the brain and nervous system. Understanding the specifics can help you navigate diagnostic tests and choose the best course of treatment.

("DyDo") has launched FIRDAPSE® (amifampridine) Tablets 10 mg in Japan for the indication of improving muscle weakness in patients living with Lambert-Eaton myasthenic syndrome ("LEMS").

Eaton Corporation plc operates as a power management company worldwide. The company’s Electrical Americas and Electrical Global segment provides electrical components, industrial components ...